Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0404237 on April 14, 2005

Published online before print April 14, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0404237v1
78/1/167    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramos, C. D. L.
Right arrow Articles by Cunha, F. Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramos, C. D. L.
Right arrow Articles by Cunha, F. Q.
(Journal of Leukocyte Biology. 2005;78:167-177.)
© 2005 by Society for Leukocyte Biology

MIP-1{alpha}[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-{alpha} and LTB4

Cleber D. L. Ramos*, Claudio Canetti*,{dagger}, Janeusa T. Souto{ddagger},§, João S. Silva{ddagger}, Cory M. Hogaboam, Sergio H. Ferreira* and Fernando Q. Cunha*,1

* Departments of Pharmacology and
{ddagger} Biochemistry and Immunology, School of Medicine of Ribeirão Preto, University of São Paulo, Brazil;
§ Department of Microbiology and Parasitology, Federal University of Rio Grande do Norte, Natal, RN, Brazil; and
{dagger} Division of Pulmonary & Critical Care Medicine and
Department of Pathology, University of Michigan, Ann Arbor

1 Correspondence: Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, USP, Avenida Bandeirantes, 3900 Ribeirão Preto, São Paulo, 14049-900 (Brazil). E-mail: fdqcunha{at}fmrp.usp.br

In the present study, we investigated the involvement of macrophage-inflammatory protein-1{alpha} (MIP-1{alpha})[CC chemokine ligand 3 (CCL3)], MIP-1ß[CCL4], regulated on activation, normal T expressed and secreted (RANTES)[CCL5], and CC chemokine receptors (CCRs) on neutrophil migration in murine immune inflammation. Previously, we showed that ovalbumin (OVA)-triggered neutrophil migration in immunized mice depends on the sequential release of tumor necrosis factor {alpha} (TNF-{alpha}) and leukotriene B4(LTB4). Herein, we show increased mRNA expression for MIP-1{alpha}[CCL3], MIP-1ß[CCL4], RANTES[CCL5], and CCR1 in peritoneal cells harvested from OVA-challenged, immunized mice, as well as MIP-1{alpha}[CCL3] and RANTES[CCL5] but not MIP-1ß[CCL4] proteins in the peritoneal exudates. OVA-induced neutrophil migration response was muted in immunized MIP-1{alpha}[CCL3]–/– mice, but it was not inhibited by treatment with antibodies against RANTES[CCL5] or MIP-1ß[CCL4]. MIP-1{alpha}[CCL3] mediated neutrophil migration in immunized mice through induction of TNF-{alpha} and LTB4 synthesis, as these mediators were detected in the exudates harvested from OVA-challenged immunized wild-type but not MIP-1{alpha}[CCL3]–/– mice; administration of MIP-1{alpha}[CCL3] induced a dose-dependent neutrophil migration, which was inhibited by treatment with an anti-TNF-{alpha} antibody in TNF receptor 1 (p55–/–)-deficient mice or by MK 886 (a 5-lipoxygenase inhibitor); and MIP-1{alpha}[CCL3] failed to induce LTB4 production in p55–/– mice. MIP-1{alpha}[CCL3] used CCR1 to promote neutrophil recruitment, as OVA or MIP-1{alpha}[CCL3] failed to induce neutrophil migration in CCR1–/– mice, in contrast to CCR5–/– mice. In summary, we have demonstrated that neutrophil migration observed in this model of immune inflammation is mediated by MIP-1{alpha}[CCL3], which via CCR1, induces the sequential release of TNF-{alpha} and LTB4. Therefore, whether a similar pathway mediates neutrophil migration in human immune-inflammatory diseases, the development of specific CCR1 antagonists might have a therapeutic potential.

Key Words: chemokines • chemokine receptors • chemotaxis




This article has been cited by other articles:


Home page
J. Immunol.Home page
C.-H. Hsieh, M. Frink, Y.-C. Hsieh, W.-H. Kan, J.-T. Hsu, M. G. Schwacha, M. A. Choudhry, and I. H. Chaudry
The Role of MIP-1{alpha} in the Development of Systemic Inflammatory Response and Organ Injury following Trauma Hemorrhage
J. Immunol., August 15, 2008; 181(4): 2806 - 2812.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. Carregaro, J. G. Valenzuela, T. M. Cunha, W. A. Verri Jr., R. Grespan, G. Matsumura, J. M. C. Ribeiro, D.-E. Elnaiem, J. S. Silva, and F. Q. Cunha
Phlebotomine salivas inhibit immune inflammation-induced neutrophil migration via an autocrine DC-derived PGE2/IL-10 sequential pathway
J. Leukoc. Biol., July 1, 2008; 84(1): 104 - 114.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. M. Kelly, K. McNagny, D. L. Williams, N. van Rooijen, L. Maxwell, C. Gwozd, C. H. Mody, and P. Kubes
The Lung Responds to Zymosan in a Unique Manner Independent of Toll-Like Receptors, Complement, and Dectin-1
Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 227 - 238.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Beauvillain, Y. Delneste, M. Scotet, A. Peres, H. Gascan, P. Guermonprez, V. Barnaba, and P. Jeannin
Neutrophils efficiently cross-prime naive T cells in vivo
Blood, October 15, 2007; 110(8): 2965 - 2973.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. P. Lambert, L. Rauova, M. Bailey, M. C. Sola-Visner, M. A. Kowalska, and M. Poncz
Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications
Blood, August 15, 2007; 110(4): 1153 - 1160.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Cittera, M. Leidi, C. Buracchi, F. Pasqualini, S. Sozzani, A. Vecchi, J. D. Waterfield, M. Introna, and J. Golay
The CCL3 Family of Chemokines and Innate Immunity Cooperate In Vivo in the Eradication of an Established Lymphoma Xenograft by Rituximab
J. Immunol., May 15, 2007; 178(10): 6616 - 6623.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y. Shiratsuchi, T. Iyoda, N. Tanimoto, D. Kegai, K. Nagata, and Y. Kobayashi
Infiltrating neutrophils induce allospecific CTL in response to immunization with apoptotic cells via MCP-1 production
J. Leukoc. Biol., February 1, 2007; 81(2): 412 - 420.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Jaradat, C. Stapleton, S. L. Tilley, D. Dixon, C. J. Erikson, J. G. McCaskill, H. S. Kang, M. Angers, G. Liao, J. Collins, et al.
Modulatory Role for Retinoid-related Orphan Receptor {alpha} in Allergen-induced Lung Inflammation
Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1299 - 1309.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. K. Logsdon and J. Mecsas
The Proinflammatory Response Induced by Wild-Type Yersinia pseudotuberculosis Infection Inhibits Survival of yop Mutants in the Gastrointestinal Tract and Peyer's Patches
Infect. Immun., March 1, 2006; 74(3): 1516 - 1527.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. A. Reichel, A. Khandoga, H.-J. Anders, D. Schlondorff, B. Luckow, and F. Krombach
Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue
J. Leukoc. Biol., January 1, 2006; 79(1): 114 - 122.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Leukocyte Biology.